# Karyopharm Therapeutics Inc.: Form 8-K, filed Mar 27, 2026

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2026-03-27
- Accepted by EDGAR: Mar 27, 2026, 08:04 ET
- Period: 2026-03-27
- Accession: 0001503802-26-000011
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000150380226000011/kpti-20260327.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000150380226000011/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000150380226000011/kpti-20260327.htm

Filed Mar 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001503802-26-000011. Last ingested by Listed: Nov 14, 2026, 19:58 ET. No prices; not investment advice.
